Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells

Oncotarget
Eisuke DomaeYoji Shimizu

Abstract

Vγ9Vδ2 T cells, the major subset of the human peripheral blood γδ T-cell, respond to microbial infection and stressed cells through the recognition of phosphoantigens. In contrast to the growing knowledge of antigen-mediated activation mechanisms, the antigen-independent and cytokine-mediated activation mechanisms of Vγ9Vδ2 T cells are poorly understood. Here, we show that interleukin (IL) -12 and IL-18 synergize to activate human ex vivo-expanded Vγ9Vδ2 T cells. Vγ9Vδ2 T cells treated with IL-12 and IL-18 enhanced effector functions, including the expression of IFN-γ and granzyme B, and cytotoxicity. These enhanced effector responses following IL-12 and IL-18 treatment were associated with homotypic aggregation, enhanced expression of ICAM-1 and decreased expression of the B- and T-lymphocyte attenuator (BTLA), a co-inhibitory receptor. IL-12 and IL-18 also induced the antigen-independent proliferation of Vγ9Vδ2 T cells. Increased expression of IκBζ, IL-12Rβ2 and IL-18Rα following IL-12 and IL-18 stimulation resulted in sustained activation of STAT4 and NF-κB. The enhanced production of IFN-γ and cytotoxic activity are critical for cancer immunotherapy using Vγ9Vδ2 T cells. Thus, the combined treatment of ex vivo-expanded Vγ9V...Continue Reading

References

Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhinan YinJoe Craft
Sep 18, 2002·Immunological Reviews·Wolfgang WeningerUlrich H von Andrian
Oct 2, 2002·European Journal of Immunology·Rance E BergJames Forman
Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dieter KabelitzMargot Zöller
Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hans-Peter RauéMark K Slifka
Aug 6, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bladimiro Rincon-OrozcoThomas Herrmann
Sep 28, 2005·Breast Cancer Research and Treatment·Ben L GuoRichard D Lopez
Oct 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Murielle CorvaisierFrancine Jotereau
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Liang ChenJoe Craft
Apr 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ronald B Smeltz
May 1, 2009·European Journal of Immunology·Olivier ToutiraisVéronique Catros
Jun 23, 2009·Nature Reviews. Immunology·Yrina RochmanWarren J Leonard
May 7, 2010·Journal of Immunotherapy·Wen LiHaruki Okamura
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tohru MiyakeOsamu Takeuchi
Jan 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Junko TsudaHaruki Okamura
Apr 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin ThurnherGeorg Gruenbacher
Jun 25, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Oliver NussbaumerMartin Thurnher
Jun 27, 2013·Oncoimmunology·Dieter KabelitzDaniela Wesch
Jul 9, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hong WangCraig T Morita
Jul 23, 2013·Nature Immunology·Stefano VavassoriGennaro De Libero
Oct 21, 2014·The Journal of Clinical Investigation·Michele ArdolinoDavid H Raulet
Feb 13, 2015·Frontiers in Immunology·Sérgio T RibeiroBruno Silva-Santos

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation
density gradient centrifugation
FACS
ChIP
Precipitation
PCR
Assay

Software Mentioned

GraphPad Prism
FlowJo
GraphPad

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.